← Back to Clinical Trials
Recruiting NCT06324942

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

Trial Parameters

Condition Cesarean Section Complications
Sponsor University of Calgary
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-02-19
Completion 2026-12
Interventions
Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg

Brief Summary

The purpose of this research study is to evaluate whether or not adding a Transversus Abdominis Plane Block (TAP block) improves pain control for patients having a cesarean section. A TAP block is a type of nerve block where at the end of the surgery an injection of a long acting local anesthetic is made into the abdominal wall. In studies in patient's having other abdominal surgeries this has reduced the amount of narcotics patients need for pain control. This may also led to patients being more active after surgery and maybe spending less time in hospital.

Eligibility Criteria

Inclusion Criteria: * ASA status II to III * All patients undergoing elective CS under regional anesthesia at any gestational age. Exclusion Criteria: * \- Known drug allergy to local anesthetics * Planned general anesthetic * NSAID use contraindicated post partum * Chronic pain disorder or chronic narcotic use/dependence * Planned vertical abdominal incision * Planned Cesarean Hysterectomy. * Placenta Previa or suspected Placenta Accreta

Related Trials